Skip to main content

Oncology

Multiple Myeloma, Oncology
Host Factors Important in Patients with Myeloma
Caroline Helwick
Read More
Multiple Myeloma, Oncology
New Data Demonstrate Overall Survival Benefit with Pomalidomide in Advanced Myeloma
Caroline Helwick
Read More
Leukemia, Oncology
Evidence Lacking for Eliminating Prophylactic Platelet Transfusions
Audrey Andrews
Read More
Leukemia, Oncology
Ibrutinib: It’s Not Just for Leukemia
Audrey Andrews
Read More
Leukemia, Oncology
Molecular and Cytogenetic Assessments Infrequently Performed in Patients with CML Receiving First-Line Imatinib
Mark Knight
Read More
Leukemia, Oncology
Alternatives to “7 + 3” Induction Therapy for AML Are Emerging
Wayne Kuznar
Read More
Leukemia, Oncology
Fast Response Identifies Patients with CML for Entry into Studies of Imatinib Discontinuation
Wayne Kuznar
Read More
Leukemia, Oncology
“Dramatic” Responses with Targeted Agent for Patients with CLL
Charles Bankhead
Read More
Leukemia, Oncology
New Oral TKI Ponatinib Produces High Response Rates in Hard-to-Treat Leukemia
Wayne Kuznar
Read More
Leukemia, Oncology
New Targeted Agent Shows Significant Success in Treating Refractory Form of AML
Wayne Kuznar
Read More
Page 23 of 27
Results 221 - 230 of 262